#Kurzgesagt claiming #Ozempic and other #GLP-1 agonists are probably pretty okay and that 55% of people don’t gain weight back after going off of them (and 80% of people don’t gain all the weight back).
on 02026-05-23#news: dropping #GLP-1 agonists like #Ozempic (though this trial was tirzepatide, aka Zepbound) results in 82% of cases of regaining more than 25% of the lost weight, in 57% of cases of regaining more than 50%, and 24% of cases of regaining more than 75%, with corresponding worsening or not of other metabolically-induced problems. #medicine
on 02025-11-26